IL28B - C-terminal region Antibody from MYBIOSOURCE INC.
Search, find, compare suppliers for anti-IL28B - C-terminal region antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | IL28B - C-terminal region |
| Clone | polyclonal |
| Host Species | Rabbit |
| Reactive Species | dog, horse, human, mouse, porcine, rabbit, rat |
| Isotype | n/a |
| Format | affinity purified |
| Size | 0.1 mL |
| Concentration | n/a |
| Applications | Western Blot (WB) |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | This antibody is pan-IL28 specific, as there is 100% homology to the human IL28A sequence, per http://www.uniprot.org/uniprot/Q8IZJ0. This is a rabbit polyclonal antibody against IL28B. It was validated on Western BlotTarget Description: This gene encodes a cytokine distantly related to type I interferons and the IL-10 family. This gene, interleukin 28A (IL28A), and interleukin 29 (IL29) are three closely related cytokine genes that form a cytokine gene cluster on a chromosomal region mapped to 19q13. Expression of the cytokines encoded by the three genes can be induced by viral infection. All three cytokines have been shown to interact with a heterodimeric class II cytokine receptor that consists of interleukin 10 receptor, beta (I |
| Immunogen | n/a |
| Other Names | [interferon lambda-3 isoform 2; Interferon lambda-3; interferon lambda-3; interferon lambda 3; Cytokine Zcyto22; Interleukin-28B; IL-28B; Interleukin-28C] |
| Gene, Accession # | [IFNL3], Gene ID: 282617, NCBI: NP_742151, UniProt: Q8IZI9 |
| Catalog # | MBS3216137 |
| Price | $335 |
| Order / More Info | IL28B - C-terminal region Antibody from MYBIOSOURCE INC. |
| Product Specific References | n/a |
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166
sales@mybiosource.com
http://www.MyBioSource.com
Profile of MYBIOSOURCE INC.
Return to Antibodies